Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of the European Academy of Dermatology and Venereology : JEADV|April 4, 2017
The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countriesT Caballero, W Aberer, H J Longhurst, et al.Clinical and Experimental Dermatology|March 24, 2012
Pyoderma gangrenosum-like ulcer caused by Helicobacter cinaedi in a patient with x-linked agammaglobulinaemiaJ Dua, E Elliot, P Bright, et al.Journal of Clinical Pathology|February 5, 2002
Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiencyH J Longhurst, C O'Grady, G Evans, et al.Allergy|December 8, 2016
Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practiceA Zanichelli, M Maurer, W Aberer, et al.Clinical and Experimental Immunology|December 10, 2016
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome SurveyH J Longhurst, A Zanichelli, T Caballero, et al.The Journal of the Royal College of General Practitioners|June 1, 1987
A simple method for the detection of Chlamydia trachomatis infections in general practiceH J Longhurst, N Flower, B J Thomas, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 10, 2021
Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome SurveyM Maurer, T Caballero, W Aberer, et al.Clinical and Experimental Immunology|April 24, 2013
In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiencyA L Manson, A Price, J Dempster, et al.Clinical and Experimental Immunology|January 22, 2015
C1 inhibitor deficiency: 2014 United Kingdom consensus documentH J Longhurst, M D Tarzi, F Ashworth, et al.Clinical and Experimental Immunology|February 26, 2005
C1 inhibitor deficiency: consensus documentM M Gompels, R J Lock, M Abinun, et al.Pageof 3